Chief Executive Officer (CEO)

Matts Johansen has been CEO of Aker BioMarine since 2015. He first joined the company in 2009 as Chief Operating Officer. Prior to his career in Aker BioMarine, Johansen served as the Chief Marketing Officer at Telefónica O2. He studied at Oslo University College and completed executive education at Columbia University.

Click image to download.

Chief Financial Officer (CFO)

Katrine Klaveness became CFO of Aker BioMarine in 2018. Prior to joining Aker BioMarine, she spent the first part of her career in McKinsey & Company, followed by several years in senior positions in Aker ASA’s investment team and Aker BP. Klaveness holds a master’s degree from BI Norwegian Business School.

Click image to download.

Executive Vice President (EVP)
People and Communications

Marte Dalsegg joined Aker BioMarine in 2017 and serves as Executive Vice President, People and Communications. Prior to joining the company, she held the position of Advisor within the Corporate Responsibility and Sustainability department at Telenor Norway. Dalsegg holds a Bachelor’s degree in Communications from Southampton Solent University.

Click image to download.

Chief Executive Officer (CEO), Human Health Ingredients

Simon Seward joined Aker BioMarine in 2019. He is now the CEO of Aker BioMarine’s Human Health Ingredient business. Prior to joining Aker BioMarine, he was SVP Sales & Marketing at Algalif and Commercial Director at NutraQ. Seward has a master’s degree in Marketing from Staffordshire University.

Click image to download.

Chairman

Ola Snøve has served as Aker BioMarine’s Chair of the Board since 2014. Previously, he was Investment Director of Aker ASA for more than ten years, and he is the former President & CEO of Epax. Snøve holds a MSc and a PhD from the Norwegian University of Science and Technology, and an MBA with Distinction from INSEAD. 

Snøve is a Norwegian citizen and as of May 2025, holds a total of 858,619 shares. Snøve has no share options.

Snøve is independent of the company’s management and material business contacts.

Click image to download

Director

Kathryn Moore Baker is an investor and professional board member with extensive experience from private equity, venture capital, and corporate governance. She was a partner at the Norwegian private equity firm Reiten & Co for 15 years and has served on the boards of numerous listed and private companies in Norway and internationally, including the Executive Board of Norges Bank. Baker holds a bachelor's degree in Economics from Wellesley College and an MBA from Tuck School of Business at Dartmouth. 

Baker is an American citizen and as of May 2026, holds no shares or share options.

Baker is independent of the company’s management and material business contacts.

Click image to download

Director, elected by the employees

Kristin Holmgren, an employee-elected representative to the Board, has been a part of Aker BioMarine since 2019. Holmgren is the company's inhouse Intellectual Property manager. Holmgren has a degree in Molecular Biology from NTNU and is in progress to be an European Patent Attorney. 

Holmgren is a Norwegian citizen and has 4,647 shares as of May 2026. Holmgren has no share options.

Click image to download

Director

Cilia Holmes Indahl leads the foundation for EQT, a global investment company. She is also the Co-founder of Sustainability Hub Norway. Indahl holds an Economics degree with a double master's degree in International Business and Sustainable Innovation from the Norwegian School of Economics (NHH) and HEC Paris.

Indahl is a Norwegian citizen and as of May 2025, holds a total of 5 shares.

Indahl is independent of the company’s main shareholder.

Click image to download

(credit: Gry May Ljøterud)

Director

Frank O. Reite (born 1970) first joined Aker in 1995 and held the position as CFO in Aker ASA from August 2015 until August 2019. He is now an advisor. He holds a B.A. in business administration from BI Norwegian Business School in Oslo. Mr. Reite has previously held the position as President & CEO of Akastor (up until 2015), and has previously also held a variety of executive positions in the Aker group, including overseeing and developing Aker’s investments in Converto Capital Fund AS, Havfisk ASA, Norway Seafoods AS and Aker Yards ASA. Mr. Reite also has experience from banking and served as Operating Director at Paine & Partners, a New York-based private equity firm. He is also chair of Akastor ASA, Converto AS and Norron AB, and director of AMSC ASA and Solstad Offshore ASA. In addition to serving as deputy chair, Mr. Reite is the head of the Audit Committee at Aker ASA.

Reite is a Norwegian citizen and had no company shares or share options as of May 2025.

Reite is independent of the company’s management and material business contacts. 

Click image to download.

Director, elected by the employees

Bilal Ahmad is an employee-elected representative to the Board of Directors of Aker BioMarine. He is the Commercial Operations Manager, responsible for initiatives in commercial strategy and pricing, sales culture, and operational efficiency, and has been a part of Aker BioMarine since August 2024.

He holds a double master's degree in International Management (CEMS MIM) from the Norwegian School of Economics and CEMS. Prior to joining Aker BioMarine, Bilal worked four years in an Oslo-based management consulting firm specializing in corporate strategy and business transformation.

Bilal Ahmad is a Norwegian citizen and holds 2369 shares in Aker BioMarine as of October 2025.

Click image to download